Top

Published in:

01-02-2004 | Poster presentation

B-type natriuretic peptide testing reduces time to discharge in patients presenting with acute dyspnea (the BASEL study)

Authors: C Mueller, A Scholer, B Martina, S Marsch

Published in: Critical Care | Special Issue 1/2004

Excerpt

In patients with pulmonary disease it is often challenging to distinguish exacerbated pulmonary disease from congestive heart failure (CHF). B-type natriuretic peptide (BNP) levels are significantly higher in CHF as compared with exacerbated pulmonary disease. …

Title: B-type natriuretic peptide testing reduces time to discharge in patients presenting with acute dyspnea (the BASEL study)
Authors: C Mueller
A Scholer
B Martina
S Marsch
Publication date: 01-02-2004
Publisher: BioMed Central
Published in: Critical Care / Issue Special Issue 1/2004
Electronic ISSN: 1364-8535
DOI: https://doi.org/10.1186/cc2752

Keynote webinar | Spotlight on medication adherence

Springer Medicine

B-type natriuretic peptide testing reduces time to discharge in patients presenting with acute dyspnea (the BASEL study)

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Special Issue 1/2004

Predicting the response to therapy from a mathematical model

Study design of a mortality trial with intravenous levosimendan (the SURVIVE study) in patients with acutely decompensated heart failure

Incidence of multidrug-resistant bacteria in a general ICU: 1-year study

Efficacy of activated recombinant factor VII (rFVIIa; NovoSeven®) in cirrhotic patients with upper gastrointestinal bleeding: a randomised placebo-controlled double-blind multicenter trial

Hemodynamic effects of the new calcium sensitiser levosimendan in cardiosurgical ICU patients

The sepsis syndromes in the emergency department